Baseline characteristics
T2DM
INSULIN RESISTANCE
The baseline characteristics of the Probiotics group and Placebo group in the PPDP study have been presented in the previous article (9). Specifically, there were no significant differences in sex composition, age, body mass index (BMI), blood pressure, heart rate, liver function, blood lipid profile, FPG, post-glucose load plasma glucose, glycated hemoglobin A1c(HbA1c), fasting serum insulin (FINS) and the homeostasis model assessment of insulin resistance (HOMA-IR) between the two groups.At the end of the PPDP study, there remained 39 patients with undiagnosed T2DM (21 patients in the Probiotics group and 18 in the Placebo group). The characteristics of undiagnosed T2DM patients at the end of 2-year follow up between the probiotics and placebo groups were shown in Characteristics of undiagnosed T2DM patients at the end of 2-year follow up between the Probiotics and Placebo groups.ALT, Alanine aminotransferase; BMI, body mass index; DBP, Diastolic blood pressure; FPG, fasting plasma glucose; FINS, fasting insulin; HOMA-IR, homeostasis model assessment of insulin resistance; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; SBP, systolic blood pressure; TC, total cholesterol; TG, Triglyceride; SCr, serum creatinine; 30minPG, 30-minute-plasma glucose post-glucose load; 2hPG, 2-h-plasma glucose post-glucose load; 30mINS, 30-minute-insulin post-glucose load; 2hINS, 2-hour-insulin post-glucose load.Categorical data were described as n (%). Continuous data are presented as mean ± SD.*P values<0.05 were considered significant.